Game Theoretic Modeling of Cancer Healthy Cell Competition: A Population Dependent Nash Equilibrium Framework

In the microscopic world of the human body, tissues are not static landscapes but active battlegrounds where cells constantly assess their neighbors. Healthy cells possess an innate ability to recognize and eliminate their weaker or damaged counterparts, a biological process known as cell competition. This mechanism acts as a natural defense system, particularly in the skin and lining of organs, where it helps prevent the formation of tumors by pushing out cells that have begun to change. For decades, scientists have tried to understand how this struggle plays out using mathematical models. Most of these models treated the interaction as a fixed game, assuming that the rules of engagement and the strength of the healthy cells' defense never changed, regardless of how many cancer cells were present. However, real biological systems are fluid; the environment shifts, populations grow and shrink, and the pressure on a cell changes depending on its surroundings. This static view has struggled to explain why tumors grow at different speeds in different people or why treatments work for some patients but fail for others.

A new study by Alireza Ebadi and Maryam Hashemi proposes a different way to look at this conflict, moving away from fixed rules toward a dynamic framework that changes as the battle unfolds. Instead of assuming the healthy cells' defense strength is constant, the researchers built a computer simulation where the ability of healthy cells to fight back depends directly on the ratio of healthy to cancer cells at any given moment. They call this a population-dependent equilibrium, meaning the "rules" of the game update themselves based on who is winning or losing in that specific moment. To test this idea, the team created a digital model of tissue, a grid representing a patch of skin or organ lining, and populated it with healthy cells and cancer cells. They watched how these virtual cells interacted over time, allowing the healthy cells to learn and adapt their defense strategies based on the changing numbers of their enemies, much like a population adjusting its behavior in response to a shifting threat.

The researchers ran thousands of simulations to see how different factors influenced the outcome. They introduced various drugs and dietary elements into the model to see if they could tip the scales back in favor of the healthy tissue. In the simulations, the healthy cells were not passive; they actively pushed against the cancer cells, and their success depended on how many of them were left to do the fighting. The study found that when the model was left alone, without any intervention, the cancer cells eventually took over, pushing the healthy cells back and expanding their territory. This result mirrored the natural progression of tumors in the absence of treatment, confirming that the model behaved in a realistic way. However, when the researchers introduced specific substances, the outcome changed dramatically. They tested seven different drugs, including aspirin and a compound called VC1-8, alongside five dietary factors like high sugar intake and smoking.

The results showed a clear hierarchy of effectiveness. Among the drugs, VC1-8 and aspirin were the most successful at helping the healthy cells hold their ground. In the simulations where these drugs were present, the healthy cells maintained a larger population, and the cancer cells were kept in check, unable to expand as aggressively. The model suggested that these drugs worked by boosting the defense strength of the healthy cells, making them more effective at eliminating their cancerous neighbors. Conversely, the dietary factors had the opposite effect. High sugar intake and smoking were the most potent drivers of cancer growth in the simulation, causing the cancer cells to expand rapidly and push the healthy cells to the brink of extinction. The study also explored what happened when drugs and bad diets were combined. The simulations revealed that a healthy diet and effective drugs could partially cancel each other out, while a bad diet could undermine the benefits of medication. This suggests that the environment in which the cells exist is just as critical as the treatment itself.

One of the most significant aspects of this work is how it handles the concept of learning. The researchers did not just program the cells to follow a set script; they allowed the system to update its understanding of the situation as the simulation progressed. They used a method called Bayesian learning, which is a way of updating beliefs based on new evidence, to track how the cells' defense strategies evolved. As the simulation ran, the model's internal estimate of the defense strength gradually aligned with the actual population numbers, showing that the system was indeed learning from the environment rather than just following a pre-written rule. This dynamic approach allowed the researchers to see that the balance between healthy and cancer cells is not a fixed point but a moving target that shifts with every interaction. The study confirmed that under a wide range of conditions, this new framework remained stable, meaning the competition between the two cell types could persist for a long time without one side immediately wiping out the other, a scenario that matches the slow, complex progression of real tumors.

The researchers were careful to note that these findings come from computer simulations, not direct experiments on human patients or animals. The numbers they used for how different drugs and foods affect the cells were estimated from existing scientific literature, not measured in their own lab. This means that while the ranking of which drugs work best and which foods are worst is likely accurate based on the data they used, the exact numbers might need adjustment once real-world measurements are available. The model also simplified the complex three-dimensional structure of human tissue into a flat, two-dimensional grid, which is a necessary step for this type of calculation but may not capture every detail of how tumors invade in the body. Despite these limitations, the study offers a powerful new tool for thinking about cancer. By treating the tumor and the healthy tissue as a dynamic system where the rules change based on the population, the researchers have provided a way to test how different combinations of treatments and lifestyle choices might work together.

This approach suggests that personalized cancer therapy could benefit from looking at the whole picture, including the patient's diet and the specific mix of drugs they receive. If a patient is taking a powerful drug but also consuming a diet that strongly promotes cancer growth, the drug might be less effective than expected. The model predicts that controlling these environmental factors is essential for the treatment to work. The study does not claim to have solved cancer or discovered a new cure, but it does offer a clearer, more flexible way to understand the struggle between healthy and cancerous cells. It moves beyond the idea of a static battle with fixed winners and losers, showing instead that the outcome depends on a continuous, shifting negotiation between the two populations. For scientists and doctors, this means that future treatments might need to be tailored not just to the genetic makeup of the tumor, but to the dynamic environment in which the tumor lives, adjusting strategies as the population of cells changes over time.